Influence of venlafaxine hydrochloride on the quality of life in patients with chronic tension headache
Hong-yu Zhou,Dong Zhou
DOI: https://doi.org/10.3321/j.issn:1673-8225.2006.10.012
2006-01-01
Abstract:AIM: To evaluate the effect of venlafaxine hydrochloride on the quality of life (QOL) in patients with chronic tension headache by taking naproxen as a control. METHODS: Totally 123 cases of chronic tension headache patients, who were treated respectively in the West China Hospital of Sichuan University, the First Affiliated Hospital of Kunming Medical College and the First Affiliated Hospital of Chongqing University of Medical Sciences form November 2002 to August 2004, were randomly divided into the test group (n=61) and control group (n=62). Patients in the test group took venlafaxine hydrochloride capsules, 25 mg for each time and twice a day, while those in the control group took naproxen pills, 2 pills for each time (0.2 g) and twice a day, the medication lasted for 14 days in both groups. The scores of QOL (daily life, daily work, sleep and mood) of both groups were observed, recorded and evaluated before medication and on the 2nd, 5th, 7th, 10th and 14th days after medication, and the life quality improvement ratios were compared after the test. The improvement ratio (%) = (pre-treatment total score - post-treatment total score) / pre-treatment total score ×100%. Therapeutic effect identification: improvement ratio≥90% as clinical control; 90% > improvement ratio ≥ 50% as obvious effect; 50% > improvement ratio ≥ 20% as progressed effect; improvement ratio < 20% or no change or worse as ineffective. The obvious effect and effective were considered as effective together. RESULTS: One case in the test group and 3 cases in the control group lost to the follow-up. Finally 119 patients entered the analysis of results with 60 cases in the test group and 59 cases in the control group. ① In the test group, the clinical control ratio was 38%, the total effective ratio was 70%, and the beneficial ratio was 90%; in the control group, the clinical control ratio was 31%, the total effective ratio was 59%, and the beneficial ratio was 81%. The effective ratio and beneficial ratio were insignificantly different between the two groups (QCMH=1.723 0, P=0.1893; QCMH=1.829 8, P=0.176 2). According to the intention-to-treat analysis, there was significant difference in the improvement of post-treatment QOL between the two groups (Z=-4.626 8, P < 0.000 1). ② There were no significant differences in the QOL scores at each time point between the two groups. ③ On the 14th day after treatment, th e score of sleep control was significantly different between the test group and control group (1.17±1.70, 1.95±2.25, t=-2.14, P=0.034 4); on the 10th day after treatment, the score of mood control was also significantly different between the test group and control group (1.73±1.73, 2.53±2.04, t=-2.29, P=0.023 8). It was indicated that, the curative effects on sleep and mood control in the test group were obviously better than those in the control group, but the scores of daily life, daily work, sleep and mood at other time points had insignificant differences between the two groups. CONCLUSION: Venlafaxine hydrochloride has a certain improving effect on the QOL of patients with chronic tension headache, and the total results are similar to those of naproxen.